Perfluorinated chemicals and fetal growth: a study within the Danish National Birth Cohort.
BACKGROUND
Perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) are man-made, persistent organic pollutants widely spread throughout the environment and human populations. They have been found to interfere with fetal growth in some animal models, but whether a similar effect is seen in humans is uncertain.


OBJECTIVE
We investigated the association between plasma levels of PFOS and PFOA in pregnant women and their infants' birth weight and length of gestation.


METHODS
We randomly selected 1,400 women and their infants from the Danish National Birth Cohort among those who completed all four computer-assisted telephone interviews, provided the first blood samples between gestational weeks 4 and 14, and who gave birth to a single live-born child without congenital malformation. PFOS and PFOA were measured by high performance liquid chromatography-tandem mass spectrometer.


RESULTS
PFOS and PFOA levels in maternal plasma were on average 35.3 and 5.6 ng/mL, respectively. Only PFOA levels were inversely associated with birth weight (adjusted beta = -10.63 g; 95% confidence interval, -20.79 to -0.47 g). Neither maternal PFOS nor PFOA levels were consistently associated with the risk for preterm birth or low birth weight. We observed no adverse effects for maternal PFOS or PFOA levels on small for gestational age.


CONCLUSIONS
Our nationwide cohort data suggest an inverse association between maternal plasma PFOA levels and birth weight. Because of widespread exposure to these chemicals, our findings may be of potential public health concern.
Fei
Chunyuan
C
Department of Epidemiology, University of California, Los Angeles, California 90095-1772, USA.
McLaughlin
Joseph K
JK
Tarone
Robert E
RE
Olsen
Jørn
J
D000328:Adult; D017738:Alkanesulfonic Acids / Q000097:blood* / Q000494:pharmacology; D001724:Birth Weight / Q000187:drug effects; D002210:Caprylates / Q000097:blood / Q000494:pharmacology; D015331:Cohort Studies; D003718:Denmark; D004781:Environmental Exposure; D005260:Female; D047109:Fetal Development / Q000187:drug effects*; D005466:Fluorocarbons / Q000097:blood* / Q000494:pharmacology; D005865:Gestational Age; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D018811:Maternal Exposure; D008431:Maternal-Fetal Exchange; D011247:Pregnancy
D017738:Alkanesulfonic Acids; D002210:Caprylates; D005466:Fluorocarbons; C023036:perfluorooctanoic acid; C076994:perfluorooctane sulfonic acid